We’re delighted to invite you to the RNA Vaccines & Therapeutics Conference London, taking place on 15-16 September 2026, at BMA House, London.
Hosted by , 51³Ô¹ÏÍø, and the , this leading conference will bring together experts from academia, biotech, pharma, and government to explore the developments shaping the next generation of RNA medicines.
As RNA technologies continue to advance, collaboration across the innovation ecosystem is essential to translate scientific discoveries into real-world solutions. The conference provides a forum to share knowledge, build partnerships, and discuss the priorities that will drive the field forward.
Over two days, attendees will gain insights into advances in RNA vaccines and therapeutics, explore challenges in manufacturing, delivery, and scale-up, and connect with peers from across the RNA ecosystem.
Featured speakers
We are excited to announce a line-up of expert speakers, including:
- William Schief, Vice-President Protein Design, Moderna.
- Norbert Pardi, Associate Professor at University of Pennsylvania Perelman School of Medicine.
- Karin Lore, Professor, Center for Molecular Medicine at the Karolinska Institutet, Stockholm.
- Saranya Sridhar, VP, Head of Global Clinical Development, Vaccines, Sanofi.
In addition to an outstanding programme of invited speakers, the conference will feature presentations and poster sessions selected through our abstract submission process, showcasing emerging research and innovative applications from across the RNA ecosystem.
Call for abstracts
We are now inviting researchers, scientists, innovators, and industry professionals to submit abstracts for oral and poster presentations. This is an excellent opportunity to share your latest work, gain visibility among key stakeholders, and contribute to discussions shaping the future of RNA-based medicines.
Whether you are advancing novel RNA technologies, developing therapeutic applications, or exploring manufacturing, delivery, or regulatory challenges, we encourage you to submit your abstract for consideration.
Early-bird registration is now open
Early-bird tickets are available for a limited time and are strictly limited in number. Once the allocation has been sold, standard registration rates will apply. We encourage you to secure your place early to take advantage of the discounted rate.
Register now
View the full agenda, submit your abstract, and register today to join the organisations and researchers advancing the next generation of RNA vaccines and therapeutics.